Is PTGX stock safe? | Glauxie AI

Q: Is PTGX stock safe?

Protagonist Therapeutics, Inc. (PTGX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Dinesh V. Patel. Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory... Employees: 132.

Q: What are the risks of investing in PTGX?

Identify key risks of investing in PTGX — debt, competition, volatility, and sector headwinds.

Q: Is PTGX a good long-term investment?

Evaluate PTGX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does PTGX have?

Review PTGX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is PTGX stock safe?

🦉

Protagonist Therapeutics, Inc. (PTGX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODinesh V. Patel

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II...

Key Executives

Name	Title
Abha Bommireddi	Executive Vice President & Chief of Staff
Arturo Molina FACP	Chief Medical Officer
Ashok Bhandari	EVP & Chief Discovery Officer
Asif Ali	Executive Vice President & Chief Financial Officer
Carena Spivey	Executive VP & Chief Human Resources Officer
Carter J. King	Executive Vice President of Business Development

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

PTGX Profile Financials

What are the risks of investing in PTGX? Is PTGX a good long-term investment? How much debt does PTGX have?